We hypothesize that induction of Egln3 during the initial stages of tumor formation impaired cellular factors that are proposed to support tumor initiation such as Hif-2α and Oct4 [2], [19] and that later stage glioma progression was abrogated through reduced angiogenic signaling within the tumor. This evidence concerns the gene EPAS1 and glioma.